Cargando…

Hemolysis From Intravenous Immunoglobulin in Obese Patients With Kawasaki Disease

Objective: We assessed the risk of IVIG-associated hemolytic anemia in patients with acute Kawasaki disease (KD) and evaluated the risk of weight-based dosing in our obese patients. Methods: IVIG-associated hemolytic anemia was assessed in acute KD patients treated with IVIG at Rady Children's...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Anh, Khanh-Van Y., Shah, Saloni, Tremoulet, Adriana H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146618/ https://www.ncbi.nlm.nih.gov/pubmed/32318529 http://dx.doi.org/10.3389/fped.2020.00146

Ejemplares similares

Editorial: Kawasaki Disease
por: Ayusawa, Mamoru, et al.
Publicado: (2021)

Intravenous immunoglobulin resistance in Kawasaki disease patients: prediction using clinical data
por: Lam, Jonathan Y., et al.
Publicado: (2023)

Comparison of Machine Learning Models for Prediction of Initial Intravenous Immunoglobulin Resistance in Children With Kawasaki Disease
por: Kuniyoshi, Yasutaka, et al.
Publicado: (2020)

Effect of Early Intravenous Immunoglobulin Therapy in Kawasaki Disease: A Systematic Review and Meta-Analysis
por: Yan, Fan, et al.
Publicado: (2020)

Nomogram to predict risk of resistance to intravenous immunoglobulin in children hospitalized with Kawasaki disease in Eastern China
por: Huang, Hongbiao, et al.
Publicado: (2022)

Circulating Immune Cell Profile and Changes in Intravenous Immunoglobulin Responsiveness Over the Disease Course in Children With Kawasaki Disease
por: Choi, In Su, et al.
Publicado: (2022)

Intravenous Methylprednisolone Pulse Therapy Versus Intravenous Immunoglobulin in the Prevention of Coronary Artery Disease in Children with Kawasaki Disease: A Randomized Controlled Trial
por: Aslani, Nahid, et al.
Publicado: (2022)

Neutrophil-to-Lymphocyte Ratio Predicts Intravenous Immunoglobulin-Resistance in Infants Under 12-Months Old With Kawasaki Disease
por: Chen, Yongbing, et al.
Publicado: (2019)

Risk Factors of Intravenous Immunoglobulin Resistance in Children With Kawasaki Disease: A Meta-Analysis of Case-Control Studies
por: Liu, Gengying, et al.
Publicado: (2020)

C-Reactive Protein to Albumin Ratio for Predicting Coronary Artery Lesions and Intravenous Immunoglobulin Resistance in Kawasaki Disease
por: Tsai, Chih-Min, et al.
Publicado: (2020)

A New Scoring System for Prediction of Intravenous Immunoglobulin Resistance of Kawasaki Disease in Infants Under 1-Year Old
por: Wu, Shu, et al.
Publicado: (2019)

Value of blood inflammatory markers for predicting intravenous immunoglobulin resistance in Kawasaki disease: A systematic review and meta-analysis
por: Liu, Chang, et al.
Publicado: (2022)

Prediction for Intravenous Immunoglobulin Resistance Combining Genetic Risk Loci Identified From Next Generation Sequencing and Laboratory Data in Kawasaki Disease
por: Chen, Liqin, et al.
Publicado: (2020)

A Machine Learning Model to Predict Intravenous Immunoglobulin-Resistant Kawasaki Disease Patients: A Retrospective Study Based on the Chongqing Population
por: Liu, Jie, et al.
Publicado: (2021)

Biomarkers for the Discrimination of Acute Kawasaki Disease From Infections in Childhood
por: Zandstra, Judith, et al.
Publicado: (2020)

Characterization of the T Cell Response to Lactobacillus casei Cell Wall Extract in Children With Kawasaki Disease and Its Potential Role in Vascular Inflammation
por: Hsieh, Li-En, et al.
Publicado: (2021)

Intravenous immunoglobulin for the treatment of Kawasaki disease
por: Broderick, Cathryn, et al.
Publicado: (2023)

Kawasaki Disease in Infants in the First 3 Months of Age in a Mexican Population: A Cautionary Tale
por: Garrido-García, Luis Martín, et al.
Publicado: (2020)

Treatment Response in Kawasaki Disease Is Associated with Sialylation Levels of Endogenous but Not Therapeutic Intravenous Immunoglobulin G
por: Ogata, Shohei, et al.
Publicado: (2013)

Risk Factors for Resistance to Intravenous Immunoglobulin Treatment and Coronary Artery Abnormalities in a Chinese Pediatric Population With Kawasaki Disease: A Retrospective Cohort Study
por: Liu, Jie, et al.
Publicado: (2022)

Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease
por: Li, Wei, et al.
Publicado: (2022)

The possible association between epidemics of hand-foot-and-mouth disease and responsiveness to immunoglobulin therapy in Kawasaki disease
por: Shimizu, Daisuke, et al.
Publicado: (2022)

Treatment of immunoglobulin-resistant kawasaki disease: a Bayesian network meta-analysis of different regimens
por: Pan, Yan, et al.
Publicado: (2023)

Use of Adjunctive Therapy in Acute Kawasaki Disease in Latin America
por: Fortuna-Reyna, Brenda, et al.
Publicado: (2020)

Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease
por: Park, Hyo Min, et al.
Publicado: (2013)

Predictors and management of intravenous immunoglobulin-resistant Kawasaki disease
por: Song, Min Seob
Publicado: (2019)

Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin
por: Galeotti, Caroline, et al.
Publicado: (2010)

Intravenous Immunoglobulin in Kawasaki Disease—Evolution and Pathogenic Mechanisms
por: Nadig, Pallavi L., et al.
Publicado: (2023)

Kawasaki Disease
por: Hedrich, Christian M., et al.
Publicado: (2018)

Efficacy of Glucocorticoid plus Intravenous Immunoglobulin in Children with Immunoglobulin-Insensitive Kawasaki Disease
por: Ma, Yongmei, et al.
Publicado: (2022)

The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?
por: Han, Ji Whan
Publicado: (2017)

Prediction of Resistance to Standard Intravenous Immunoglobulin Therapy in Kawasaki Disease
por: Lee, Sang Min, et al.
Publicado: (2014)

Intravenous Immunoglobulin Treatment in Kawasaki Disease Decreases the Incidence of Myopia
por: Yu, Hun-Ju, et al.
Publicado: (2021)

Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease
por: Lu, Yaheng, et al.
Publicado: (2021)

The Epidemiology and Pathogenesis of Kawasaki Disease
por: Rowley, Anne H., et al.
Publicado: (2018)

Epigenetics in Kawasaki Disease
por: Sharma, Kaushal, et al.
Publicado: (2021)

Efficacy of Intravenous Immunoglobulin/Exchange Transfusion Therapy on Gestational Alloimmune Liver Disease
por: Yeh, Pai-Jui, et al.
Publicado: (2021)

Retracted: Efficacy of Glucocorticoid plus Intravenous Immunoglobulin in Children with Immunoglobulin-Insensitive Kawasaki Disease
por: Healthcare Engineering, Journal of
Publicado: (2023)

Kawasaki Disease and Allergic Diseases
por: Huang, Po-Yu, et al.
Publicado: (2021)

Factors Predicting Resistance to Intravenous Immunoglobulin and Coronary Complications in Kawasaki Disease: IVIG Resistance in Kawasaki Disease
por: Han, Ji Whan
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_oqguj90h4pf1fdkgpj2mm743m0